Anbio Biotechnology Class A Ordinary Shares (NNNN) Earnings History
Annual and quarterly earnings data from 2021 to 2024
Loading earnings history...
NNNN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NNNN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 71.9% | 24.4% | 29.0% |
| 2023 | 50.1% | 29.2% | 33.6% |
| 2022 | 53.4% | 43.3% | 42.5% |
| 2021 | 57.4% | 55.5% | 57.3% |
Download Data
Export NNNN earnings history in CSV or JSON format
Free sign-in required to download data
Anbio Biotechnology Class A Ordinary Shares (NNNN) Earnings Overview
As of May 6, 2026, Anbio Biotechnology Class A Ordinary Shares (NNNN) reported trailing twelve-month net income of $5M, reflecting +366.7% year-over-year growth. The company earned $0.12 per diluted share over the past four quarters, with a net profit margin of 29.0%.
Looking at the long-term picture, NNNN's historical earnings data spans multiple years. The company achieved its highest annual net income of $10M in fiscal 2022.
Anbio Biotechnology Class A Ordinary Shares maintains industry-leading profitability with a gross margin of 71.9%, operating margin of 24.4%, and net margin of 29.0%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including CLOV (-$86M net income, -4.4% margin), ACHC (-$1.11B net income, -33.3% margin), QDEL (-$1.21B net income, -41.5% margin), NNNN has outperformed on profitability metrics. Compare NNNN vs CLOV →
NNNN Earnings vs Peers
Earnings metrics vs comparable public companies
NNNN Historical Earnings Data (2021–2024)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $2M | +5.3% | $2M | $0.06 | 29.0% | 24.4% |
| 2023 | $2M | -77.5% | $2M | $0.01 | 33.6% | 29.2% |
| 2022 | $10M | +294.8% | $10M | $0.07 | 42.5% | 43.3% |
| 2021 | $3M | - | $2M | $0.03 | 57.3% | 55.5% |
See NNNN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NNNN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NNNN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNNNN — Frequently Asked Questions
Quick answers to the most common questions about buying NNNN stock.
Is NNNN growing earnings?
NNNN EPS is $0.12, with earnings growth accelerating to +366.7%. This exceeds the 5-year CAGR of N/A. TTM net income reached $5M.
What are NNNN's profit margins?
Anbio Biotechnology Class A Ordinary Shares net margin is +29.0%, with operating margin at +24.4%. Above-average margins indicate pricing power.
How consistent are NNNN's earnings?
NNNN earnings data spans 2021-2024. The accelerating earnings trend is +366.7% YoY. Historical data enables comparison across business cycles.